Provisional patent applications are popular in the U.S. for the various advantages they may provide applicants, including lower filing costs, less restrictive United States Patent and Trademark Office ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. You have a great idea for an invention, and you think it is ...

ITC is designed to serve as a centralized marketplace for filed provisional patent applications, enabling companies to identify and evaluate early-stage intellectual property opportunities in a ...

Patent applicants often file provisional applications at the United States Patent and Trademark Office (USPTO) to secure a priority date before filing a full-blown utility patent application for their ...

“Refiling a provisional is just a bad idea when you can, for a few hundred dollars more, keep hold of that earliest priority date and continue on the path to obtaining a patent.” The question that we ...

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...

LegalZoom Launches Streamlined Provisional Patent Filing Product to Help Businesses and Entrepreneurs Protect Intellectual Property, Secure Funding and Drive Growth LegalZoom’s law firm to provide ...

TUCSON, Ariz., March 2, 2026 /PRNewswire/ -- Keys Inc. today announced the filing of U.S. Provisional Patent Application No. 63/939,152 with the United States Patent and Trademark Office (USPTO) ...

Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications The provisional patent application describes novel nanoparticle ...

CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today notes the announcement issued by Sarborg Limited (“Sarborg”) regarding the filing of a U.S. provisional patent application relating to its ...

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (RAPH), a clinical-stage biotechnology company developing an innovative research platform based on cannabinoids free of THC and ...